Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
37.00
-3.83 (-9.38%)
At close: Dec 5, 2025, 4:00 PM EST
37.20
+0.20 (0.54%)
After-hours: Dec 5, 2025, 7:51 PM EST
Anbio Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 8.19 | 6.71 | 23.54 | 4.43 |
| Revenue Growth (YoY) | 21.95% | -71.49% | 431.67% | - |
| Cost of Revenue | 2.3 | 3.35 | 10.98 | 1.89 |
| Gross Profit | 5.89 | 3.36 | 12.56 | 2.54 |
| Selling, General & Admin | 3.44 | 1.27 | 2.17 | 0.09 |
| Research & Development | 0.45 | 0.13 | 0.2 | - |
| Operating Expenses | 3.89 | 1.4 | 2.37 | 0.09 |
| Operating Income | 2 | 1.96 | 10.2 | 2.46 |
| Interest Expense | - | - | -0.01 | - |
| Interest & Investment Income | 0.34 | 0.17 | 0.04 | - |
| Currency Exchange Gain (Loss) | 0.02 | 0.12 | -0.26 | -0 |
| Other Non Operating Income (Expenses) | 0.02 | 0.01 | 0.04 | 0.08 |
| Pretax Income | 2.37 | 2.25 | 10.01 | 2.54 |
| Net Income | 2.37 | 2.25 | 10.01 | 2.54 |
| Net Income to Common | 2.37 | 2.25 | 10.01 | 2.54 |
| Net Income Growth | 5.29% | -77.49% | 294.79% | - |
| Shares Outstanding (Basic) | 42 | 21 | - | - |
| Shares Outstanding (Diluted) | 42 | 21 | - | - |
| Shares Change (YoY) | 97.30% | - | - | - |
| EPS (Basic) | 0.06 | 0.11 | - | - |
| EPS (Diluted) | 0.06 | 0.11 | - | - |
| EPS Growth | -46.63% | - | - | - |
| Gross Margin | 71.90% | 50.07% | 53.36% | 57.40% |
| Operating Margin | 24.38% | 29.22% | 43.30% | 55.46% |
| Profit Margin | 28.99% | 33.58% | 42.52% | 57.26% |
| EBIT | 2 | 1.96 | 10.2 | 2.46 |
| EBIT Margin | 24.38% | 29.22% | 43.30% | 55.46% |
| Revenue as Reported | 8.19 | 6.71 | 23.54 | 4.43 |
Source: S&P Capital IQ. Standard template.
Financial Sources.